(Adnkronos) • Treatments for rheumatological diseases have made important progress, thanks to increasingly targeted therapies that allow better control of pathologies and improve the quality of life of patients. However, the goals achieved are still open challenges: late diagnosis, inequalities in access to treatment, difficulties in the continuity of care and emerging risks, [...]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
(Adnkronos) - Treatments for rheumatological diseases have made important progress, thanks to increasingly targeted therapies that allow you to better control pathologies and improve the quality of life of patients.